搜索

quanfu quanfu

Product Center

Homepage
/
News
/
Company news
/
The Phase I clinical launch meeting of the 23 valent pneumococcal polysaccharide vaccine was successfully held

The Phase I clinical launch meeting of the 23 valent pneumococcal polysaccharide vaccine was successfully held

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2022-05-24
  • Views:

(Summary description)The golden autumn is refreshing, and the fruit is fragrant. In this harvest season, we usher in a promising new chapter. The sound of the song is far away, and the Qi River is flowing. In Qi County, Hebi City, Henan Province, a famous historical and cultural city in China, the launch meeting of the Phase I clinical research project of the 23-valent pneumococcal polysaccharide vaccine jointly developed by Ab&B Bio-Tech CO.,LTD.JS and Beijing Huaan Kechuang Biotechnology Co., Ltd. was successfully held.

The Phase I clinical launch meeting of the 23 valent pneumococcal polysaccharide vaccine was successfully held

(Summary description)The golden autumn is refreshing, and the fruit is fragrant. In this harvest season, we usher in a promising new chapter. The sound of the song is far away, and the Qi River is flowing. In Qi County, Hebi City, Henan Province, a famous historical and cultural city in China, the launch meeting of the Phase I clinical research project of the 23-valent pneumococcal polysaccharide vaccine jointly developed by Ab&B Bio-Tech CO.,LTD.JS and Beijing Huaan Kechuang Biotechnology Co., Ltd. was successfully held.

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2022-05-24 16:08
  • Views:
Information
The golden autumn is refreshing, and the fruit is fragrant. In this harvest season, we usher in a promising new chapter. The sound of the song is far away, and the Qi River is flowing. In Qi County, Hebi City, Henan Province, a famous historical and cultural city in China, the launch meeting of the Phase I clinical research project of the 23-valent pneumococcal polysaccharide vaccine jointly developed by Ab&B Bio-Tech CO.,LTD.JS and Beijing Huaan Kechuang Biotechnology Co., Ltd. was successfully held.
The kick-off meeting was presided over by Wang Yanxia, ​​deputy director of the Henan Provincial Center for Disease Control and Prevention. Leaders such as Guo Wanshen, director of the Henan Provincial Center for Disease Control and Prevention, and Zhu Jiangbo, deputy mayor of Qi County, attended the kick-off meeting and delivered important speeches. Mr. An Youcai, chairman and general manager of Ab&B Bio-Tech CO.,LTD.JS gave a detailed introduction to the company's development and vaccine overview.
The kick-off meeting organized detailed training and drills for this clinical program. Dr. Shi Weiwei from Beijing Huaan Kechuang Biotechnology Co., Ltd. conducted the 23-valent pneumococcal polysaccharide vaccine researcher's manual training; Mr. Wang Yanxia, ​​deputy director of the Henan Provincial Center for Disease Control and Prevention, conducted the quality management standard for drug clinical trials (GCP) and the clinical trial of this project. Program training; Mr. Zhang Wei from Henan Provincial Center for Disease Control and Prevention explained the clinical quality control of vaccines and related standard operating procedures; Mr. Guo Qi, project manager of Beijing Zhongsheng Hengyi Pharmaceutical Technology Co., Ltd., a clinical supervision agency, conducted training on clinical research operation procedures.
At the Qixian County Center for Disease Control and Prevention, the participants participated in the on-site simulation exercise, and completed a series of exercises such as on-site simulated reception, informed consent, sample collection, physical examination inquiry, random allocation, vaccination, and post-free observation according to functional areas. . Adhering to the principle of all for the subjects during the exercise, always follow the requirements of the regulations to carry out carefully, meticulously and comprehensively, and find and correct problems in a timely manner. Through on-the-spot simulation drills, it is ensured that every experimenter can complete the clinical trial skillfully and efficiently.
Sometimes when riding the wind and breaking the waves, the sails are hung straight to the sea. Ab&B Bio-Tech CO.,LTD.JS will continue to uphold the work spirit of being rigorous, serious, pragmatic, self-disciplined, and always insisting on struggle. Seek well-being!
 
The golden autumn is refreshing, and the fruit is fragrant. In this harvest season, we usher in a promising new chapter. The sound of the song is far away, and the Qi River is flowing.
Scan the QR code to read on your phone
Previous: Ab&B Bio Tech CO., LTD. JS has been awarded multiple BioCon Awards for 2022!
Next: The No. 2 plant of the vaccine industrialization project was successfully started
Previous: Ab&B Bio Tech CO., LTD. JS has been awarded multiple BioCon Awards for 2022!
Next: The No. 2 plant of the vaccine industrialization project was successfully started

Relevant information

Have a project？Get a touch!

Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio

Contact

E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City

Quick view

Follow us

Copyright © 2022 Ab&B Bio-Tech CO.,LTD.JS All Rights Reserved.   Powered by:www.300.cn
Verification 苏ICP备16005775号-1
Search